Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

LSI Medience to Launch Cancer Drug Discovery Support Service Using Avatar Mice

Filed Under: Innovation, Pharma Tagged With: , , , , , , , ,

LSI Medience Corp., a subsidiary of Mitsubishi Chemical Holdings Corp. (TYO:4188), plans this March to begin a drug discovery support…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models
Tokyo Institute of Technology, Kanto Chemical Develop Growth…
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Tokyo Tech Devises a New Generation of BPA for Use in…
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…